Related Experiment Video
Updated: Feb 8, 2026

Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia
Minodora Dobreanu1, Catrinel Gălăţeanu, Agneta Simionescu
1Department of Clinical Biochemistry, U.M.P. Tîrgu Mureş, Gh. Marinescu 38, 4300 Tîrgu Mureş.
Insights
Atorvastatin significantly reduced LDL cholesterol and inflammatory markers like CRP and homocysteine in patients with severe primary hypercholesterolemia. These anti-inflammatory effects may contribute to clinical benefits beyond cholesterol lowering.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Biochemistry
Background:
- Emerging evidence links atherosclerosis, inflammation, and hypercholesterolemia.
- Severe primary hypercholesterolemia (PHC) presents significant cardiovascular risk.
- Statins, HMG CoA reductase inhibitors, are primary treatments for hypercholesterolemia.
Purpose of the Study:
- To investigate the influence of Atorvastatin on inflammatory parameters in patients with severe PHC.
- To assess Atorvastatin's effects on serum lipids, apoproteins, and specific inflammatory markers.
- To evaluate potential anti-inflammatory mechanisms of statin therapy.
Main Methods:
- A study involving 21 patients with severe PHC, 12 with significant coronary-artery stenosis.
- Baseline measurements included lipids, apoproteins, CRP, sICAM, lipid peroxides, Ab oxLDL, and homocysteine.
- Patients received Atorvastatin 40 mg daily for 8 weeks after a 4-week baseline period.
Main Results:
- Atorvastatin significantly reduced LDL-C (57.8%), total Cholesterol (44.08%), Apo B (50.6%), and TG.
- In patients with coronary heart disease, Atorvastatin decreased homocysteine (19.41%) and CRP (21.9%).
- Atorvastatin reduced lipid peroxides (TBARS) by 52% but did not significantly affect sICAM or Ab oxLDL.
Conclusions:
- Atorvastatin effectively modulates LDL-C and exhibits anti-inflammatory effects, reducing CRP and homocysteine.
- These anti-inflammatory actions may contribute to the clinical benefits of statins, independent of lipid-lowering.
- Plaque stabilization through anti-inflammatory mechanisms is a potential key action of statin therapy.
Abstract:
Recent publications have reanimated the point of view that there exist links between atherosclerosis--inflammation and hypercholesterolemia. The aim of our study was to investigate the possible influence of statins on some inflammatory parameters in persons with severe primary hypercholesterolemia (PHC). The effects of the HMG CoA reductase inhibitor--Atorvastatin--on serum lipids, apoproteins, C reactive protein (CRP), soluble Intercellular Adhesion Molecule (sICAM), lipid peroxides, antibodies to oxidized LDL (Ab oxLDL) and homocystein were evaluated in 21 persons (52.9 +/- 8.38 years old) with severe PHC, 12 of these having significant coronary-artery stenosis (diameter stenosis > or = 70%), in at least one major coronary artery branch. Ab oxLDL, sICAM, TBARS, CRP and homocystein were significantly increased (p < 0.05) in patients with coronary-artery stenosis. Following a 4 weeks hypolipemiant free baseline period, all persons were treated with Atorvastatin 40 mg once daily for 8 weeks. Atorvastatin 40 mg resulted in a reduction of LDL-C with 57.8% (baseline 259.6 +/- 71.39 mg%) p < 0.001, total Cholesterol with 44.08% (baseline 343.1 +/- 71.72 mg%) p < 0.001, Apo B with 50.6% (baseline 194.7 +/- 48.71 mg%) p < 0.001, TG with 12.02% (baseline 177.4 +/- 83.63 mg%) and HDL-C was increased with 6.84% (baseline 48.0 +/- 7.86 mg%). In coronary heart disease patients, Atorvastatin reduced homocystein concentrations with 19.41% (baseline 17.7 +/- 11.16 microM/l) (p < 0.01), and CRP with 21.9% (baseline 4.8 +/- 4.19 mg/l) p < 0.01 and TBARS with 52% (baseline 0.87 +/- 0.89 nM/ml) p < 0.001, but did not influence sICAM and Ab oxLDL. Thus atherogenic concentrations of LDL-C have to be closely modulated by minimal changes in LDL oxidative state. The effects of Atorvastatin on inflammatory parameters may crucially contribute to the clinical benefit of statins, independent of cholesterol lowering. Plaque stabilization may be a paradigm for antiinflammatory mechanism of action by this class of drugs.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
Wave Parameters
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Distributions to Estimate Population Parameter

